Elizabeth Crain
Chairman at EXSCIENTIA PLC
Net worth: 281 287 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Andrew Hopkins | M | 52 |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 12 years |
| Kenneth Moelis | M | 65 |
Moelis Asset Management LP
 Moelis Asset Management LP Investment Banks/BrokersFinance Moelis Asset Management LP provides investment banking services. It capabilities include private equity, credit and structured products. The company was founded by Ken Moelis in 2007 and is headquartered in New York, NY.
The Wharton School of the University of Pennsylvania
| 17 years |
| Ben Taylor | M | 46 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 years |
| David Hallett | M | 54 | 4 years | |
| Marie Bober | F | - |
Moelis Asset Management LP
Moelis Asset Management LP Investment Banks/BrokersFinance Moelis Asset Management LP provides investment banking services. It capabilities include private equity, credit and structured products. The company was founded by Ken Moelis in 2007 and is headquartered in New York, NY. | 11 years |
| Dan Ireland | M | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | - |
| Esa Ville Ilmari Niinimäki | M | 48 | 17 years | |
| Sari Maritta Baldauf | F | 68 | 6 years | |
| C. Nicholson | M | 68 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 years |
| Kai Öistämö | M | 59 | 2 years | |
| Joseph Ansanelli | M | 54 |
The Wharton School of the University of Pennsylvania
| - |
| Thomas Saueressig | M | 39 | 2 years | |
| Bennett Rosenthal | M | 60 |
The Wharton School of the University of Pennsylvania
| - |
| Mario Polywka | M | 61 | 7 years | |
| Sara Blum Sherman | F | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 3 years |
| Pekka Ilmari Lundmark | M | 61 | 4 years | |
| Eric Jonathan Felder | M | - |
Moelis Asset Management LP
Moelis Asset Management LP Investment Banks/BrokersFinance Moelis Asset Management LP provides investment banking services. It capabilities include private equity, credit and structured products. The company was founded by Ken Moelis in 2007 and is headquartered in New York, NY. | - |
| Carla M. S. Smits-Nusteling | F | 57 | 8 years | |
| Robert Ghenchev | M | 41 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 years |
| Douglas Applegate | M | - |
Moelis Asset Management LP
Moelis Asset Management LP Investment Banks/BrokersFinance Moelis Asset Management LP provides investment banking services. It capabilities include private equity, credit and structured products. The company was founded by Ken Moelis in 2007 and is headquartered in New York, NY. | - |
| Joanne Xu | F | 46 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 3 years |
| Garry Pairaudeau | M | 58 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 4 years |
| Amanda Galgay | F | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 2 years |
| Chris Thomas | M | - |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | 5 years |
| Lisa Hook | F | 66 | 2 years | |
| Thomas Dannenfeldt | M | 57 | 4 years | |
| Ian Marcus | M | 65 |
The Wharton School of the University of Pennsylvania
| - |
| Jeffrey Sloan | M | 56 |
The Wharton School of the University of Pennsylvania
| - |
| Robert Rosner | M | 64 |
The Wharton School of the University of Pennsylvania
| - |
| Howard Sanders | M | 58 |
The Wharton School of the University of Pennsylvania
| - |
| Dan Lauer | M | 61 |
The Wharton School of the University of Pennsylvania
| - |
| Gang Yu | M | 64 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Osamu Watanabe | M | 63 |
Moelis & Company UK Holdings B Ltd.
 Moelis & Company UK Holdings B Ltd. Financial ConglomeratesFinance Founded in 2018, Moelis & Company UK Holdings B Ltd. is a company that functions as an investment holding company. Part of Moelis & Co., the company is based in London, UK. | 6 years |
| Rosanna Liliam Ramos Velita | F | - |
The Wharton School of the University of Pennsylvania
| - |
| Juan Pujadas | M | 62 |
The Wharton School of the University of Pennsylvania
| - |
| Alexander Gijs van Tienhoven | M | - |
The Wharton School of the University of Pennsylvania
| - |
| Karin Sigrid Thorburn | M | 60 |
The Wharton School of the University of Pennsylvania
| - |
| Göran Seifert | M | 75 |
The Wharton School of the University of Pennsylvania
| - |
| Sherman Ching Ma | M | - |
The Wharton School of the University of Pennsylvania
| - |
| Lizann Rode | F | - |
The Wharton School of the University of Pennsylvania
| - |
| Lori Rosenkopf | F | - |
The Wharton School of the University of Pennsylvania
| - |
| Howard Kaufold | M | - |
The Wharton School of the University of Pennsylvania
| - |
| Lynne Lichtenstein Tarnopol | F | - |
The Wharton School of the University of Pennsylvania
| - |
| Tony Cai | M | 57 |
The Wharton School of the University of Pennsylvania
| - |
| Jagmohan Singh Raju | M | - |
The Wharton School of the University of Pennsylvania
| - |
| Kwok Fung Lam | M | 50 |
The Wharton School of the University of Pennsylvania
| 3 years |
| Roberto Moses Thompson Motta | M | 65 |
The Wharton School of the University of Pennsylvania
| - |
| E. Vandecruze | F | 61 |
The Wharton School of the University of Pennsylvania
| - |
| Linda Shein | F | 63 |
The Wharton School of the University of Pennsylvania
| 11 years |
| Antonio Carrillo Rule | M | 57 |
The Wharton School of the University of Pennsylvania
| - |
| John Riady | M | 38 |
The Wharton School of the University of Pennsylvania
| - |
| Todd Sinai | M | 54 |
The Wharton School of the University of Pennsylvania
| 27 years |
| Miguel Heras Castro | M | 55 |
The Wharton School of the University of Pennsylvania
| 5 years |
| Suzanne Shank | F | 62 |
The Wharton School of the University of Pennsylvania
| - |
| Stefan Bichsel | M | 69 |
The Wharton School of the University of Pennsylvania
| - |
| Marc Rowan | M | 61 |
The Wharton School of the University of Pennsylvania
| - |
| Mohammed Al-Shaya | M | - |
The Wharton School of the University of Pennsylvania
| - |
| Robert W. Holthausen | M | 76 |
The Wharton School of the University of Pennsylvania
| 35 years |
| Jorge Born | M | 62 |
The Wharton School of the University of Pennsylvania
| - |
| Jacob Doft | M | 54 |
The Wharton School of the University of Pennsylvania
| - |
| Karen Finerman | F | 58 |
The Wharton School of the University of Pennsylvania
| - |
| Beth Kaplan | F | 66 |
The Wharton School of the University of Pennsylvania
| - |
| Rowland Moriarty | M | 77 |
The Wharton School of the University of Pennsylvania
| - |
| William F. Hamilton | M | 84 |
The Wharton School of the University of Pennsylvania
| - |
| Thomas P. Gerrity | M | 82 |
The Wharton School of the University of Pennsylvania
| 34 years |
| Arthur Collins | M | 76 |
The Wharton School of the University of Pennsylvania
| - |
| Hope Taitz | F | 59 |
The Wharton School of the University of Pennsylvania
| 8 years |
| Qiang Chang Sun | M | 67 |
The Wharton School of the University of Pennsylvania
| - |
| Richard C. Marston | M | 80 |
The Wharton School of the University of Pennsylvania
| 52 years |
| L. David Mounts | M | 60 |
The Wharton School of the University of Pennsylvania
| - |
| Stephen Anthony CuUnjieng | M | 64 |
The Wharton School of the University of Pennsylvania
| 9 years |
| Richard Herring | M | 78 |
The Wharton School of the University of Pennsylvania
| 52 years |
| Joshua Kazam | M | 47 |
The Wharton School of the University of Pennsylvania
| - |
| Edward Shapiro | M | 59 |
The Wharton School of the University of Pennsylvania
| - |
| Mitchell Blutt | M | 66 |
The Wharton School of the University of Pennsylvania
| - |
| Thomas S. Robertson | M | 81 |
The Wharton School of the University of Pennsylvania
| 17 years |
| Jeff Blau | M | 55 |
The Wharton School of the University of Pennsylvania
| - |
| Jacqueline Reses | F | 54 |
The Wharton School of the University of Pennsylvania
| 4 years |
| Luis Virata | M | 70 |
The Wharton School of the University of Pennsylvania
| - |
| David Blitzer | M | 55 |
The Wharton School of the University of Pennsylvania
| - |
| Farid Harianto | M | 68 |
The Wharton School of the University of Pennsylvania
| 24 years |
| Glenn Welling | M | 53 |
The Wharton School of the University of Pennsylvania
| - |
| Jawaid Mirza | M | 66 |
The Wharton School of the University of Pennsylvania
| - |
| Ricardo Alberto Salmon | M | 52 |
The Wharton School of the University of Pennsylvania
| - |
| Shiv Vikram Khemka | M | 61 |
The Wharton School of the University of Pennsylvania
| - |
| Bikram Bakshi | M | - |
The Wharton School of the University of Pennsylvania
| 6 years |
| John Jeffrey Ying | M | 62 |
The Wharton School of the University of Pennsylvania
| - |
| Paul J. H. Schoemaker | M | - |
The Wharton School of the University of Pennsylvania
| - |
| W. Frank Fountain | M | 79 |
The Wharton School of the University of Pennsylvania
| - |
| Sandeep Achyut Naik | M | 51 |
The Wharton School of the University of Pennsylvania
| 11 years |
| Chao Li Lim | M | 58 |
The Wharton School of the University of Pennsylvania
| - |
| Kenneth Shropshire | M | 69 |
The Wharton School of the University of Pennsylvania
| 38 years |
| Roy Kuan | M | 57 |
The Wharton School of the University of Pennsylvania
| - |
| Scott Mills | M | 55 |
The Wharton School of the University of Pennsylvania
| - |
| Aditya Mittal | M | 47 |
The Wharton School of the University of Pennsylvania
| - |
| Mandy Puri | F | 64 |
The Wharton School of the University of Pennsylvania
| - |
| William J. Quinn | M | 53 |
The Wharton School of the University of Pennsylvania
| - |
| Peter Huntsman | M | 61 |
The Wharton School of the University of Pennsylvania
| - |
| Frank Bruno | M | 59 |
The Wharton School of the University of Pennsylvania
| - |
| Nicolas Topiol | M | - |
The Wharton School of the University of Pennsylvania
| - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 79 | 79.00% |
| United Kingdom | 13 | 13.00% |
| Finland | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Elizabeth Crain
- Personal Network
